Company intelligence / Profile preview

Granotec

Ownership: Private
Development stage: Commercial

Overview

Granotec is not engaged in clinical development or therapeutic research. It specializes in fortification of foods and beverages with vitamins and minerals, enzyme blends for food processing, specialty chemicals for industrial use—including supply to pharmaceutical manufacturers—and nutrition technology solutions for the food industry. The Brazilian subsidiary was acquired by Corbion to expand its biobased ingredient portfolio.

Industry: Food & Nutrition

Partnerships

Grupo BIMBO (collaborative R&D projects)various industrial clients including pharmaceutical manufacturers for specialty chemicals

Beyond the preview

Go deeper on Granotec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Granotec.

Explore the full profile